Birdwatch Note
2024-04-22 16:23:33 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
There's no evidence the drug midazolam was used to kill thousands of COVID patients. There is no evidence that midazolam was being used with the intention of ending care home residents’ lives https://fullfact.org/health/midazolam-video-matt-hancock/
Written by 77F3621FF8FA173FA4ACD668DF010C276EAE695AC375074FD5F7766FA71A337C
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1782401107932660147
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1782445143343173948
- noteId - 1782445143343173948
- participantId -
- noteAuthorParticipantId - 77F3621FF8FA173FA4ACD668DF010C276EAE695AC375074FD5F7766FA71A337C Participant Details
- createdAtMillis - 1713803013058
- tweetId - 1782401107932660147
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- There's no evidence the drug midazolam was used to kill thousands of COVID patients. There is no evidence that midazolam was being used with the intention of ending care home residents’ lives https://fullfact.org/health/midazolam-video-matt-hancock/
Note Status History
| createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
| 2024-04-22 16:23:33 UTC (1713803013058) |
2024-04-22 22:41:57 UTC (1713825717631) |
CURRENTLY_RATED_HELPFUL | 2024-04-23 09:11:27 UTC (1713863487030) |
NEEDS_MORE_RATINGS | 2024-04-22 22:41:57 UTC (1713825717631) |
CURRENTLY_RATED_HELPFUL |
Note Ratings
| rated at | rated by | |
| 2024-04-22 22:29:41 -0500 | Rating Details | |
| 2024-04-22 18:04:27 -0500 | Rating Details | |
| 2024-04-22 16:52:03 -0500 | Rating Details | |
| 2024-04-22 14:38:51 -0500 | Rating Details | |
| 2024-04-22 14:26:19 -0500 | Rating Details | |
| 2024-04-22 14:26:13 -0500 | Rating Details | |
| 2024-04-22 14:20:10 -0500 | Rating Details | |
| 2024-04-22 13:59:16 -0500 | Rating Details | |
| 2024-04-22 13:45:06 -0500 | Rating Details | |
| 2024-04-22 13:17:35 -0500 | Rating Details | |
| 2024-04-22 12:49:32 -0500 | Rating Details | |
| 2024-04-22 11:31:40 -0500 | Rating Details | |
| 2024-04-22 11:29:37 -0500 | Rating Details | |
| 2024-04-23 11:03:12 -0500 | Rating Details | |
| 2024-04-23 08:15:10 -0500 | Rating Details | |
| 2024-04-22 18:18:33 -0500 | Rating Details | |
| 2024-04-22 12:49:58 -0500 | Rating Details | |
| 2024-04-22 12:15:15 -0500 | Rating Details | |
| 2024-04-22 12:00:04 -0500 | Rating Details | |
| 2024-04-25 02:20:50 -0500 | Rating Details | |
| 2024-04-22 22:47:36 -0500 | Rating Details | |
| 2024-04-22 17:00:57 -0500 | Rating Details | |
| 2024-04-22 14:26:41 -0500 | Rating Details | |
| 2024-04-22 11:32:06 -0500 | Rating Details | |
| 2024-04-22 11:30:55 -0500 | Rating Details | |
| 2024-04-22 21:00:40 -0500 | Rating Details | |
| 2024-04-23 01:45:03 -0500 | Rating Details | |
| 2024-04-23 01:00:14 -0500 | Rating Details | |
| 2024-04-22 17:13:47 -0500 | Rating Details | |
| 2024-04-22 14:07:58 -0500 | Rating Details | |
| 2024-04-22 13:29:03 -0500 | Rating Details | |
| 2024-04-22 13:13:37 -0500 | Rating Details | |
| 2024-04-22 11:51:55 -0500 | Rating Details | |
| 2024-04-22 11:29:55 -0500 | Rating Details | |
| 2024-04-22 18:25:23 -0500 | Rating Details |